Stay updated on Pembrolizumab in HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in HCC Clinical Trial page.

Latest updates to the Pembrolizumab in HCC Clinical Trial page
- Check6 days agoChange DetectedThe study page now indicates that enrollment is closed, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a revision update to v3.6.0 and formatting adjustments to the Intervention/Treatment label.SummaryDifference0.5%

- Check14 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedAdded the revision label 'Revision: v3.5.4' and removed 'Revision: v3.5.3'. This reflects an update to the page's revision history rather than any substantive change to trial data or content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page footer version has been updated from Revision: v3.5.2 to Revision: v3.5.3, indicating a platform/version change rather than an update to the study record itself.SummaryDifference0.1%

- Check63 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded hepatocellular carcinoma keyword and a new Genetic and Rare Diseases Information Center resources link. Revision updated to v3.5.0.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HCC Clinical Trial page.